PlexusDx Semaglutide Oral is also a compounded oral product, not Rybelsus
The dosage is typically increased gradually to help reduce the risk of side effects
This means that for a bioactive agent, like L-Carnitine, to exert its desired effect, it must be in physical contact with its physiological target
PlexusDx supports this precision approach by offering both genetic predisposition context and guidance on which compounded GLP-1 options (semaglutide, tirzepatide, or microdose protocols) may align with your personalized risk-benefit profile and budget
If your BMI falls below the threshold for compounded GLP-1, you may still be a candidate for our Microdosing program, a lower dose protocol built for patients seeking the metabolic, appetite, and longevity benefits of GLP-1 therapy at a gentler entry point
That's how it's supposed to work